Tempus AI PE Ratio 2023-2026 | TEM

Current and historical p/e ratio for Tempus AI (TEM) from 2023 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Tempus AI PE ratio as of June 04, 2026 is 0.00.

Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Tempus AI PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-06-05 46.43 0.00
2026-03-31 45.22 $-1.72 0.00
2025-12-31 59.05 $-1.41 0.00
2025-09-30 80.71 $1.45 55.66
2025-06-30 63.54 $1.45 43.82
2025-03-31 48.24 $-5.16 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $7.677B $1.272B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $24.733B 27.19
Hims & Hers Health (HIMS) United States $4.429B 38.86
Doximity (DOCS) United States $3.888B 16.84
IRhythm Holdings (IRTC) United States $3.724B 0.00
10x Genomics (TXG) United States $2.973B 0.00
Privia Health (PRVA) United States $2.810B 131.59
Hinge Health (HNGE) United States $2.789B 0.00
Heartflow (HTFL) United States $2.311B 0.00
Omnicell (OMCL) United States $1.564B 43.00
Inspire Medical Systems (INSP) United States $1.555B 20.94
Enovis (ENOV) United States $1.405B 7.40
Butterfly Network (BFLY) United States $1.047B 0.00
Azenta (AZTA) United States $1.023B 41.13
Clover Health Investments (CLOV) United States $1.013B 0.00
Talkspace (TALK) United States $0.864B 103.40
Schrodinger (SDGR) United States $0.839B 0.00
Phreesia (PHR) United States $0.490B 50.38
Fulgent Genetics (FLGT) United States $0.429B 0.00
Standard BioTools (LAB) United States $0.345B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.322B 0.00
CapsoVision (CV) United States $0.311B 0.00
Senseonics Holdings (SENS) United States $0.279B 0.00
Claritev (CTEV) United States $0.269B 0.00
TruBridge (TBRG) United States $0.268B 8.60
Evolent Health (EVH) United States $0.260B 0.00
Carlsmed (CARL) United States $0.239B 0.00
KORU Medical Systems (KRMD) United States $0.196B 0.00
Zepp Health (ZEPP) Netherlands $0.189B 0.00
CareCloud (CCLD) United States $0.115B 8.18
Nyxoah SA (NYXH) Belgium $0.111B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
American Well (AMWL) United States $0.086B 0.00
Outset Medical (OM) United States $0.077B 0.00
Health Catalyst (HCAT) United States $0.073B 0.00
Pulmonx (LUNG) United States $0.058B 0.00
111 (YI) China $0.057B 0.00
NetraMark Holdings (AINMF) Canada $0.052B 0.00
Precipio (PRPO) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.047B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
P3 Health Partners (PIII) United States $0.018B 0.00
EUDA Health Holdings (EUDA) Singapore $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.009B 0.00
Zhongchao (ZCMD) China $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00